Oncternal Therapeutics Inc. buy Oppenheimer Holdings Inc.
Start price
22.03.23
/
50%
€0.60
Target price
22.03.24
€8.34
Performance (%)
-55.62%
End price
23.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by Oppenheimer_Holdings for Oncternal Therapeutics Inc. is performing very badly with a performance of -55.62%. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oncternal Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.080% | -2.933% | 12.885% |
iShares Nasdaq 100 | 0.362% | 7.015% | 36.826% |
iShares Nikkei 225® | -1.155% | -1.155% | 5.073% |
iShares S&P 500 | 0.806% | 4.388% | 30.269% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $14.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for ONCT provided by MarketBeat
In the thread Trading Oncternal Therapeutics Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten